An antibody that targets the TWEAK receptor (Fn14) has been previously shown to reverse the symptoms of cachexia in tumour‐bearing mouse models and extend the lifespan of mice by restoring their body weight. This evidence concerns the gene TNFRSF12A and neoplasm.